Marshall Wace
VOR icon

Marshall Wace’s Vor Biopharma VOR Stock Holding History

Marshall Wace’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.6M Buy
+1,153,276
New +$16.3M 0.02% 695
2025
Q2 		– Sell
-933
Closed -$13.4K – 3219
2025
Q1 		$13.4K Sell
933
-927
-50% -$22.3K ﹤0.01% 2569
2024
Q4 		$41.3K Sell
1,860
-3,972
-68% -$65.8K ﹤0.01% 2494
2024
Q3 		$81.6K Buy
5,832
+1,776
+44% +$32.4K ﹤0.01% 2394
2024
Q2 		$81.1K Buy
4,056
+240
+6% +$7.76K ﹤0.01% 2407
2024
Q1 		$181K Buy
+3,816
New +$168K ﹤0.01% 2252
2023
Q2 		– Sell
-2,504
Closed -$269K – 3000
2023
Q1 		$269K Buy
2,504
+980
+64% +$109K ﹤0.01% 2329
2022
Q4 		$203K Buy
+1,524
New +$151K ﹤0.01% 2700

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace's VOR Position: Q1 2026 in Review

Marshall Wace opened a new position in Vor Biopharma (VOR) in Q1 2026: 1,153,276 shares worth $20.6M. The stake represents 0.02% of the portfolio and ranks #695 among its holdings. This is a return to the name: Marshall Wace previously reported a position in VOR as recently as Q1 2025.

Marshall Wace first reported a position in VOR in Q4 2022 and has held it in 8 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Marshall Wace held 1,153,276 shares of Vor Biopharma worth $20.6M as of Q1 2026.
  • Vor Biopharma was a new Marshall Wace position in Q1 2026.
  • Vor Biopharma made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #695 holding.
  • Marshall Wace first reported a position in Vor Biopharma in Q4 2022 and has held it in 8 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.